The 69th American Academy of Neurology Annual Meeting
The AAN Annual Meeting "is the world's largest gathering of neurologists, bringing together more than 10,000 neurology professionals across the globe to network, discuss cutting-edge research, and take part in top-rated education programming across a wide variety of topics."
Peter Goadsby, M.B., B.S., Director of the NIHR- Wellcome Trust Kingâ€™s Clinical Research, London, Professor of Neurology, University of California at San Francisco, explained the benefits of the recent FDA approval of the gammaCore non-invasive vagal nerve stimulator on patients suffering from cluster headaches.
Larry Altstiel, MD, PhD, EVP, Chief Medical Officer, vTv Therapeutics also discussed their teamâ€™s programs in type 2 diabetes. One is an activator of an enzyme called glucocynase â€“ a master regulator for glucose in the body. According to Altstiel, when glucose is too high, it either shuns it off to energy production or stores it in the form of glycogen. Itâ€™s an insulin independent way of how the body controls glucose.